Why the Right Diagnosis Matters: Meet a Doctor Working to Get it Right and Hear How Avery Inspires Him
Brain tumors in children can sound especially daunting – but some brain tumors can be malignant and not especially life-threatening. Therefore, getting an accurate diagnosis is key, and Dr. James Olson of Seattle Children’s Hospital is working on more accurately diagnosing and treating brain cancers in children.
It might seem that Department of Defense technology that’s used to detect explosives might not have any use in diagnosing childhood cancers. But, if you ask St. Baldrick’s Foundation “Rockstar Researcher” Dr. Bruce Shiramizu, this technology has real potential to help patients, parents, caregivers, and the cancer community.
It’s why this Hawaii-based doctor, who has worked on the mainland at the University of California San Francisco and at the National Institutes of Health, is so passionate about his research work and what it might be able to do for children throughout the world. This veteran researcher has shaved his head multiple times for St. Baldrick’s – that’s one definition of a “Rockstar Researcher” – and his body of work speaks volumes.
Today, Feb. 15, 2019, marks this year’s International Childhood Cancer Day.
While the St. Baldrick’s Foundation might be thought of as just an American organization, the fact is that the research we fund has global reach – so we thought that we’d share a few snapshots of just how global our organization really is, and how our funding and your support are making a true impact for kids with cancer throughout the world.
It’s Valentine’s Day and that means exchanging cards, chocolates, teddy bears, and flowers with loved ones. The prevailing symbol of Valentine’s Day is the heart – which makes sense, given that the day is all about showing love and affection.
Because the heart is so central to Valentine’s Day, it’s a useful time to reflect on how childhood cancers impact this vital organ. Unfortunately, childhood cancers affect far more than the parts of the body in which they emerge – brain cancer doesn’t just harm the brain; leukemia doesn’t just affect the blood; and bone cancers often spread to the major organs.
February 4th is World Cancer Day. Established in 2000 at the World Summit Against Cancer in Paris, World Cancer Day promotes awareness, research, and services dedicated to helping people conquer cancer.
It’s an appropriate time, then, to reflect on the efforts of the St. Baldrick’s Foundation to fight childhood cancers around the world.
Founded in New York City and currently headquartered in Los Angeles, St. Baldrick’s has deep roots in the United States. But the organization has been very active beyond America’s borders, funding a variety of promising research projects that can help fight childhood cancers in the near and distant future.
For the 11th consecutive year, Dr. Alex Huang will be shaving his head for kids’ cancer research. A pediatric oncologist and professor at Cleveland’s Case Western Reserve University (CWRU) and the Angie Fowler AYA Cancer Institute at University Hospitals Rainbow Babies & Children’s Hospital, he’s no stranger to the fight against childhood cancers.
In fact, as an accomplished cancer fighter who’s dedicated time – and hair! – to helping raise money for childhood cancer research, he’s the very definition of a “Rockstar Shavee”.
Dr. Alex Huang, winner of a St. Baldrick’s Innovation Award, will shave his head for an 11th time this year.
A new drug approved by the Food & Drug Administration (FDA) is great news for childhood cancer patients.
The drug – known as larotrectnib, or Vitrakvi – is the first developed to target a key genetic driver of cancer, rather than a specific type of tumor. In this case, the drug targets a gene fusion called NTRK, found in some patients with many different types of cancer.
Dr. Federman, a St. Baldrick’s Scholar from 2009 to 2014, was directly involved in Vitrakvi’s development.
Most six-year-old boys spend their time thinking about toys, candy and getting to school on time. Few need to worry about their health at such a young age, and even fewer face the uncertain future following a cancer diagnosis.
Fighting cancer was Zach’s world when he was six. In 2007, he was diagnosed with acute lymphoblastic leukemia, or ALL. Over the next four years, Zach underwent intense and physically demanding treatments like chemotherapy and radiation.
With the holiday season upon us and another year drawing to a close, it’s a great time to reflect on some of the major research accomplishments of doctors and scientists whose work on childhood cancers benefited from the support of St. Baldrick’s donors like you.
There’s much to be thankful for. All things considered, 2018 was a remarkably successful year for childhood cancer research, with much of that success spurred on by grants funded by St. Baldrick’s. Of course, none of this would have been possible without our generous donors.
Dr. Kohanbash’s cutting-edge research on ependymomas is supported by a Hero Fund in memory of Henry Cermak, who passed away in 2008 after a long, 2-year fight that included many surgeries, chemo regimens, and 93 rounds of radiation.
Just over three years ago, the St. Baldrick’s Foundation created its Robert J. Arceci Innovation Award. Designed to give innovative childhood cancer researchers unfettered freedom to explore, it has become one of the most unique and impactful initiatives in pediatric cancer funding.
Today, St. Baldrick’s is pleased to announce that Dr. Laura Broutier of Lyon, France, is the newest recipient of the award.
Dr. Laura Broutier of Lyon, France, the newest recipient of the Robert J. Arceci Innovation Award.
Older Posts »